Paper34299136
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
Tazzari M and 9 others. Int J Mol Sci, 2021. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention. Papers, record 34299136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34299136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Immunotherapy | Major topic |
| Molecular Targeted Therapy | Major topic |
| Sarcoma | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RF-2016-02362609 | Ministero della Salute | PubMed | ||
| BRI2017 | Ministero della Salute | PubMed |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32351889 | Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. | Front Oncol | 2020 | https://conductscience.org/library/papers/32351889 | PubMed |
| 2 | 33864502 | Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma. | Cancer Immunol Immunother | 2021 | https://conductscience.org/library/papers/33864502 | PubMed |
| 3 | 33254023 | High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies. | EBioMedicine | 2020 | https://conductscience.org/library/papers/33254023 | PubMed |
| 4 | 29220302 | Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29220302 | PubMed |
| 5 | 30762585 | Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor. | J Clin Invest | 2019 | https://conductscience.org/library/papers/30762585 | PubMed |
| 6 | 29301958 | A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. | Science | 2018 | https://conductscience.org/library/papers/29301958 | PubMed |
| 7 | 32873319 | Comprehensive profiling of immune-related genes in soft tissue sarcoma patients. | J Transl Med | 2020 | https://conductscience.org/library/papers/32873319 | PubMed |
| 8 | 34107450 | Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis. | Eur J Cancer | 2021 | https://conductscience.org/library/papers/34107450 | PubMed |
| 9 | 33495604 | Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. | Nat Med | 2021 | https://conductscience.org/library/papers/33495604 | PubMed |
| 10 | 33567262 | Germline genetic contribution to the immune landscape of cancer. | Immunity | 2021 | https://conductscience.org/library/papers/33567262 | PubMed |
| 11 | 29301960 | Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. | Science | 2018 | https://conductscience.org/library/papers/29301960 | PubMed |
| 12 | 32313726 | Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors. | Oncoimmunology | 2020 | https://conductscience.org/library/papers/32313726 | PubMed |
| 13 | 30018380 | Integrated genetic and epigenetic analysis of myxofibrosarcoma. | Nat Commun | 2018 | https://conductscience.org/library/papers/30018380 | PubMed |
| 14 | 28988646 | Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28988646 | PubMed |
| 15 | 31078463 | Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/31078463 | PubMed |
| 16 | 28662235 | Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/28662235 | PubMed |
| 17 | 32670260 | Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation. | Front Immunol | 2020 | https://conductscience.org/library/papers/32670260 | PubMed |
| 18 | 21873989 | Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. | Nat Med | 2011 | https://conductscience.org/library/papers/21873989 | PubMed |
| 19 | 28110710 | Imatinib in Dermatofibrosarcoma: Targeted Therapy or Immunotherapy? | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/28110710 | PubMed |
| 20 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926214 | Single-cell analysis reveals the potential immunoregulatory role of C3 + malignant cell subpopulations in dedifferentiated liposarcoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42926214 | PubMed |
| 42871792 | Molecular genetic analysis of a case report of undifferentiated pleomorphic sarcoma with rhabdomyosarcomatous differentiation: insights from whole-exome sequencing and literature review. | AME Case Rep | 2026 | https://conductscience.org/library/papers/42871792 | PubMed |
| 42840281 | Lymphocyte-to-monocyte ratio predicts survival in localized osteosarcoma in Vietnamese patients. | iScience | 2026 | https://conductscience.org/library/papers/42840281 | PubMed |
| 42714310 | Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42714310 | PubMed |
| 42675610 | Real-world experience with ipilimumab in combination with nivolumab in advanced sarcoma: a retrospective analysis including ultra-rare sarcomas. | Oncologist | 2026 | https://conductscience.org/library/papers/42675610 | PubMed |
| 42505406 | Immunotherapy in Soft Tissue Sarcomas-An Ongoing Quest. | Cells | 2026 | https://conductscience.org/library/papers/42505406 | PubMed |
| 42505381 | Signals Alongside Scans: A Genomics-Guided Framework for Liquid Biopsy in Bone and Soft-Tissue Sarcomas. | Cells | 2026 | https://conductscience.org/library/papers/42505381 | PubMed |
| 42437510 | Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application. | J Surg Oncol | 2026 | https://conductscience.org/library/papers/42437510 | PubMed |
| 42355971 | Efficacy and Tolerability of Pazopanib in Elderly Patients with Advanced Soft Tissue Sarcoma: A Multicentre Real-World Study from Turkey. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355971 | PubMed |
| 42254925 | Case Report: A case of primary renal synovial sarcoma. | Front Surg | 2026 | https://conductscience.org/library/papers/42254925 | PubMed |
| 41899177 | Tumor Size Modifies the Survival Benefit of Chemotherapy in Localized Soft Tissue Sarcomas: A Propensity-Matched Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41899177 | PubMed |
| 41630035 | A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas. | J Transl Med | 2026 | https://conductscience.org/library/papers/41630035 | PubMed |
| 41200607 | Therapeutic Challenges in Metastatic Myxofibrosarcoma: A Case-Based Review. | Cureus | 2025 | https://conductscience.org/library/papers/41200607 | PubMed |
| 41114372 | Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomas. | Front Oncol | 2025 | https://conductscience.org/library/papers/41114372 | PubMed |
| 40978026 | Identification and comprehensive analysis of an immune-related gene prognostic model for indicating tumor immune microenvironment features in soft tissue sarcoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/40978026 | PubMed |
| 40805205 | Comprehensive Receptor Repertoire and Functional Analysis of Peripheral NK Cells in Soft Tissue Sarcoma Patients. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805205 | PubMed |
| 40579407 | Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40579407 | PubMed |
| 40523919 | Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas. | Nat Commun | 2025 | https://conductscience.org/library/papers/40523919 | PubMed |
| 40495762 | OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40495762 | PubMed |
| 40370451 | Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience. | Front Immunol | 2025 | https://conductscience.org/library/papers/40370451 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34299136
GET https://conductscience.org/api/papers/v1/34299136/references?page=2